Relief Therapeutics - eine COVID-19 Hoffnung? (Seite 988)
eröffnet am 11.03.20 17:46:44 von
neuester Beitrag 10.05.24 10:12:00 von
neuester Beitrag 10.05.24 10:12:00 von
Beiträge: 14.085
ID: 1.321.697
ID: 1.321.697
Aufrufe heute: 37
Gesamt: 2.519.150
Gesamt: 2.519.150
Aktive User: 0
ISIN: CH1251125998 · WKN: A3EFB5 · Symbol: RLF
1,2550
CHF
+0,40 %
+0,0050 CHF
Letzter Kurs 17:31:28 SIX Swiss (CHF)
Neuigkeiten
TitelBeiträge |
---|
31.05.23 · wO Chartvergleich |
Werte aus der Branche Biotechnologie
Wertpapier | Kurs | Perf. % |
---|---|---|
1,0450 | +14.021,62 | |
40,80 | +100,00 | |
6,8900 | +30,00 | |
1,7870 | +28,56 | |
37,22 | +22,39 |
Wertpapier | Kurs | Perf. % |
---|---|---|
7,8165 | -26,67 | |
1,7000 | -31,17 | |
2,2450 | -33,58 | |
2,7600 | -38,32 | |
3,5500 | -55,46 |
Beitrag zu dieser Diskussion schreiben
Die Firmen selber müssen ihr Produkt für den Edison Award vorschlagen und eine Registrierungsgebühr zahlen:
Nomination Fees
Please note that there is a nomination fee which must be paid before the nomination will be considered eligible for judging. Payment must be made via a credit card through an online payment system.
Nominate early in the season to take advantage of the early bird discounts and
maximize your exposure to our audience.
NOW THROUGH OCT. 30, 2020 OCT. 31–NOV. 20, 2020
Corporate $1095 $1395
Non-Profit $600 $800
Student Innovator $150 $250
D.h. RLF/NeuroRX müssen diese Kurzvorstellung betr. SAMIVIR da eingereicht haben mit diesem Text.
Das läßt m.E. nur einen Schluß zu : RLF/NeuroRX wissen schon zu 100%, daß sie die FDA Zulassung bekommen werden. Alles andere gibt für mich keinen Sinn...
Nomination Fees
Please note that there is a nomination fee which must be paid before the nomination will be considered eligible for judging. Payment must be made via a credit card through an online payment system.
Nominate early in the season to take advantage of the early bird discounts and
maximize your exposure to our audience.
NOW THROUGH OCT. 30, 2020 OCT. 31–NOV. 20, 2020
Corporate $1095 $1395
Non-Profit $600 $800
Student Innovator $150 $250
D.h. RLF/NeuroRX müssen diese Kurzvorstellung betr. SAMIVIR da eingereicht haben mit diesem Text.
Das läßt m.E. nur einen Schluß zu : RLF/NeuroRX wissen schon zu 100%, daß sie die FDA Zulassung bekommen werden. Alles andere gibt für mich keinen Sinn...
Antwort auf Beitrag Nr.: 65.493.769 von Goldbarren999 am 26.10.20 09:33:42
Korrektur: SAMIVIR natürlich.
Zitat von Goldbarren999: Hintergrund:
SamiAir wurde anscheinend für den Edison Award 2021 nominiert:
https://edisonawards.com/nomineegallery2021.php
Kuriose Sache. War das ein Leak ?
Korrektur: SAMIVIR natürlich.
Auf https://twitter.com/pedroalfonsode3?lang=de gibts folgendes zu sehen:
Er schreibt dazu: Verwirrter Investor Pedro
@PedroAlfonsoDe3
-·
33 Min.
Ich habe die Diskussion gesehen, ob es sich um ein Leck, eine Fälschung usw. handelt. Ich denke, es ist ein Fehler und sie haben es zu früh gepostet! Sonst wären es nur falsche Behauptungen und ein einfacher Weg zum Betrug: "Pedros ewige Jugend-Serum" zahlt 1000$ und boomt beste Betrugs-Publizität...Nominierung braucht Beweise (glaube ich) $RLFTF
Übersetzt mit www.DeepL.com/Translator (kostenlose Version)
Hintergrund:
SamiAir wurde anscheinend für den Edison Award 2021 nominiert:
https://edisonawards.com/nomineegallery2021.php
Kuriose Sache. War das ein Leak ?
Er schreibt dazu: Verwirrter Investor Pedro
@PedroAlfonsoDe3
-·
33 Min.
Ich habe die Diskussion gesehen, ob es sich um ein Leck, eine Fälschung usw. handelt. Ich denke, es ist ein Fehler und sie haben es zu früh gepostet! Sonst wären es nur falsche Behauptungen und ein einfacher Weg zum Betrug: "Pedros ewige Jugend-Serum" zahlt 1000$ und boomt beste Betrugs-Publizität...Nominierung braucht Beweise (glaube ich) $RLFTF
Übersetzt mit www.DeepL.com/Translator (kostenlose Version)
Hintergrund:
SamiAir wurde anscheinend für den Edison Award 2021 nominiert:
https://edisonawards.com/nomineegallery2021.php
Kuriose Sache. War das ein Leak ?
Antwort auf Beitrag Nr.: 65.491.111 von mustang7173 am 25.10.20 19:55:09Sehe ich auch so, wenn big money hier mal rein kommt dann .....to the moon
Wenn die Zulassung kommt werden die Kurse nicht nur steigen, sondern Raketenartig hochschießen.mM
Ab Mittwoch kann täglich die Zulassung kommen, die Kurse könnten die Woche steigen
Wo sind denn all die klugen Menschen hin, die hier Wochenlang jedes Wochenende was gepostet haben ? War doch immer was. Mal gab’s zu viel Aktien, mal dieses, oder jenes.
bald sollte da was gehen ich werde Position noch aufstocken Montag...nach allem was ich gesehen habe ist RLF-100 das mit Abstand wirksamste Mittel gegen Covid-19 und hat am wenigsten Nebenwirkungen.
FDA Zulassung ist nur eine Frage der Zeit und dann explodiert der Kurs, wenn ich die Umsatzvolumen anschaue als Medikament sollte Relief dann gegen 10 Mia Wert sein
https://moneymidnight.com/2020/10/covid-coronavirus-sets-rel…
FDA Zulassung ist nur eine Frage der Zeit und dann explodiert der Kurs, wenn ich die Umsatzvolumen anschaue als Medikament sollte Relief dann gegen 10 Mia Wert sein
https://moneymidnight.com/2020/10/covid-coronavirus-sets-rel…
bacl on RLFTF after this!!
Today is Friday the 16.October 2020 and I would like to remind you of the following:
We hold the patent on RLF100 and the process for its synthesis. - We show the best results of any Covid drug I have ever seen. - We block the virus from attaching to host cells in the lung AND... we prevent the cytokine storm AND... reduce inflammation! - We have already been approved by the FDA as safe. - Our intravenous RLF100 was submitted to the EUA on 17.9. - pending FDA approval. - Our clinical studies with RLF100 have reached the preliminary 102 patients on September 30th - awaiting the results. - Our clinical trial for the RLF100 treatment inhaler has been designed, submitted and is expected to be completed later this year. - Our clinical trial for the RLF100 PREVENTATIVE Inhaler has been designed, submitted and is expected to be completed next year. - We are promising for lung applications other than Covid, which also need to be investigated and tested separately. - We signed a collaboration agreement with the Institute of Arthritis and Infectious Diseases of the NIH to test RLF-100 against the influenza virus and other viruses that attack the lung. - We signed a contract with Bachem Americas to manufacture a drug substance for 1 million patients. - We signed a contract with Nephron Pharma to produce enough RLF100 for 1 million patients. - We signed a contract with the largest supplier of inhaled sterile drugs in the United States to deliver RLF-100 overnight to any U.S. hospital. - In Israel, we have received the protocol for Accompanying Care, and we are in the process of deciding how to implement this protocol. - NeuroRX's CEO, Dr. Javitt, is in the top 1% of the cited scientists worldwide, has successfully guided 7 drugs through the FDA process and has held key leadership positions under Presidents Clinton, Bush Jr., Bush Sr. and Reagan. - Robert Bestoff, Chief of Operations of NeuroRX, spent his career with Lilly & Pfizer. At Pfizer, he led the entire neuroscience and pain division and was responsible for $10 billion of their drugs. - NeuroRX's manufacturing coordinator, Rich Siegel, is the former head of Johnson & Johnson's drug portfolio. - Relief has just appointed industry veteran Jack Weinstein as CFO AND retained former CFO Jeremy Meinen as Principal Finance and Accounting Officer. - Doctor (and Congressman) Andy Harris is 1 of 3 experts on the Data Monitoring Committee. Our team is of the highest caliber. Our team is focused. We make steady, precise progress. When it's time to "go"... the world will know!
https://stockhouse.com/companies/bullboard?symbol=rlftf&post…
Today is Friday the 16.October 2020 and I would like to remind you of the following:
We hold the patent on RLF100 and the process for its synthesis. - We show the best results of any Covid drug I have ever seen. - We block the virus from attaching to host cells in the lung AND... we prevent the cytokine storm AND... reduce inflammation! - We have already been approved by the FDA as safe. - Our intravenous RLF100 was submitted to the EUA on 17.9. - pending FDA approval. - Our clinical studies with RLF100 have reached the preliminary 102 patients on September 30th - awaiting the results. - Our clinical trial for the RLF100 treatment inhaler has been designed, submitted and is expected to be completed later this year. - Our clinical trial for the RLF100 PREVENTATIVE Inhaler has been designed, submitted and is expected to be completed next year. - We are promising for lung applications other than Covid, which also need to be investigated and tested separately. - We signed a collaboration agreement with the Institute of Arthritis and Infectious Diseases of the NIH to test RLF-100 against the influenza virus and other viruses that attack the lung. - We signed a contract with Bachem Americas to manufacture a drug substance for 1 million patients. - We signed a contract with Nephron Pharma to produce enough RLF100 for 1 million patients. - We signed a contract with the largest supplier of inhaled sterile drugs in the United States to deliver RLF-100 overnight to any U.S. hospital. - In Israel, we have received the protocol for Accompanying Care, and we are in the process of deciding how to implement this protocol. - NeuroRX's CEO, Dr. Javitt, is in the top 1% of the cited scientists worldwide, has successfully guided 7 drugs through the FDA process and has held key leadership positions under Presidents Clinton, Bush Jr., Bush Sr. and Reagan. - Robert Bestoff, Chief of Operations of NeuroRX, spent his career with Lilly & Pfizer. At Pfizer, he led the entire neuroscience and pain division and was responsible for $10 billion of their drugs. - NeuroRX's manufacturing coordinator, Rich Siegel, is the former head of Johnson & Johnson's drug portfolio. - Relief has just appointed industry veteran Jack Weinstein as CFO AND retained former CFO Jeremy Meinen as Principal Finance and Accounting Officer. - Doctor (and Congressman) Andy Harris is 1 of 3 experts on the Data Monitoring Committee. Our team is of the highest caliber. Our team is focused. We make steady, precise progress. When it's time to "go"... the world will know!
https://stockhouse.com/companies/bullboard?symbol=rlftf&post…
Relief Therapeutics - eine COVID-19 Hoffnung?